MRNA Moderna Inc
Company Analysis
Latest News
🟢 Moderna Inc extends move to 5.4% up
MRNA is trading at $48.49, up 5.4% versus the comparison close of $45.99 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc is trading 4.1% up today as growth and biotech stocks rebound
Moderna Inc is trading 4.1% up at $47.89 today, recovering part of yesterday’s pullback and recent volatility as broader markets trend higher. • The move...
🔴 Moderna Inc is trading 4% down today amid a broader tech pullback and rate concerns
Moderna Inc is trading 4% down today at $45.81, sliding alongside a broader pullback in tech and growth stocks as investors react to higher-for-longer rate...
🔴 Moderna Inc is trading 4.1% down today on broad tech weakness and rate fears despite positive trial news
Moderna Inc is trading 4.1% down today at $45.64, underperforming as tech and growth stocks slide amid renewed higher-for-longer interest rate fears. • The...
Moderna and Oxford University Get UK Approval for Cancer Prevention Vaccine Trial
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) authorized Moderna and the University of Oxford to begin a Phase 1/2 clinical trial. This...
🔴 Moderna Inc is trading 5.7% down today on profit-taking after a cancer vaccine-driven rally
Moderna Inc is trading 5.7% down at $48.65 as the stock consolidates gains following a sharp two-day rally. • The recent surge was driven by upbeat cancer...
🔴 Moderna Inc is trading 4.3% down today as it consolidates gains after a cancer vaccine-driven rally
Moderna Inc is trading 4.3% down at $49.37 as the stock consolidates gains following a significant multi-day surge driven by positive clinical data. • The...
🟢 Moderna Inc is trading 5% up today as investors cheer positive 5-year cancer vaccine data
Moderna Inc is trading 5% up at $51.61, continuing a multi-day rally after the company presented highly positive long-term data for its personalized cancer...
🟢 Moderna Inc is trading 4.9% up today on 2026 growth outlook and pipeline progress
Moderna Inc is trading 4.9% up now at $51.46 as investors continue to re-rate the stock following its recent first-quarter update and reiterated 2026 growth...
Moderna Vaccine Slashes Melanoma Recurrence 49%, Confirming Five-Year Durability
Moderna and Merck announced positive five-year results for their personalized mRNA cancer vaccine, intismeran autogene (mRNA-4157), combined with...
🔴 Moderna Inc is trading 5.1% down today on potential profit-taking after a strong 2026 rally
Moderna Inc is trading 5.1% down today at $44.77, giving back a portion of its significant year-to-date gains following a sizeable rally earlier in 2026. •...
Moderna targets mid-August vaccine launch, following FDA strain selection vote
Moderna participated in the U.S. FDA’s Vaccines and Related Biological Products Advisory Committee meeting on May 28, 2026. The panel voted to recommend the...
FDA Panel Backs Updated COVID Vaccines, Targeting Dominant XFG Variant
An FDA advisory panel recommended updating COVID-19 vaccines for the 2026-2027 season on May 28, 2026. The committee voted 8-1, with one abstention, to target...
New Research Reveals Broader Mechanism for mRNA Vaccine Efficacy
A new study reveals mRNA vaccines generate immune responses through non-immune cells, such as muscle cells. This challenges the dogma that these vaccines must...
Moderna and Merck Slash Recurrence Risk 49% in Five-Year Cancer Study
Moderna and Merck released five-year data from the Phase IIb KEYNOTE-942 study. The trial evaluated the personalized cancer vaccine intismeran autogene...
🟢 MRNA is trading 5.1% up today on easing rate jitters and a broad biotech rebound
MRNA is trading 5.1% up today at $48.06 as the biotech sector bounces back amid easing interest rate jitters and renewed dip-buying interest. • The stock is...
🟢 MRNA is trading 5.1% up today as biotech rebounds from rate-driven selloff
MRNA is trading 5.1% up at $48.04 as the stock stages a relief bounce following yesterday's rate-driven biotech selloff. • Recent weakness was tied to surging...
🔴 MRNA is trading 5% down today as rising yields pressure biotech and growth names
MRNA is trading 5% down at $45.69 as rising Treasury yields and a risk-off market tone weigh on the biotech sector. • Shares are sliding alongside broader...
🔴 Moderna is trading 4.01% down today amid broader biotech weakness and rising yields
Moderna is trading 4.01% down at $46.18 as shares extend a multi-day slide, tracking broader biotech weakness and a risk-off market environment. • Higher...
WHO recommends LP.8.1 vaccine update, boosting protection against new variants
The World Health Organization's (WHO) Technical Advisory Group recommends updating future COVID-19 vaccines to a monovalent LP.8.1 formulation. This guidance...